查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715837

臨床試驗供應與物流市場按服務、採購模式、類型、交付方式、最終用戶、治療領域和臨床試驗階段分類 - 2025-2030 年全球預測

Clinical Trial Supply & Logistics Market by Services, Sourcing Model, Type, Mode of Delivery, End-user, Therapeutic Area, Phases of Clinical Trials - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年臨床試驗用品和物流市場價值為 243.3 億美元，預計 2024 年將成長至 262 億美元，複合年成長率為 7.75%，預計到 2030 年將達到 410.4 億美元。

主要市場統計數據
基準年2023年 243.3億美元
預計2024年 262億美元
預測年份 2030 410.4億美元
複合年成長率（%） 7.75%

在當今快節奏的環境中，臨床實驗供應和物流部門是藥物開發過程中至關重要的環節。臨床試驗曾經是一種傳統方法，但現在正在迅速發展以滿足日益複雜的研究方案、日益嚴格的監管環境以及全球臨床試驗地點網路的要求。該報告全面概​​述了該行業中新興的尖端技術，並為深入研究市場動態奠定了基礎。這些故事是透過結合尖端技術、創新籌資策略和適應性物流解決方案來建構的，這些解決方案解決了臨床試驗每個階段的細微差別。認知到保持敏感臨床實驗藥物的完整性和及時交付的重要性，行業領導者被迫重組其供應鏈。隨著行業走向更全面、全面的方法，從製造和包裝到標籤和儲存的每個環節都受到嚴格審查。本次討論將重點介紹各相關人員為簡化業務所做的開創性努力，以便高效、安全地向有需要的人提供新型療法。

臨床試驗格局的變革

近年來，臨床試驗產業經歷了幾次變革，重新定義了臨床實驗產品的管理方式。數位連接的進步加上強大的數據分析為更具預測性和敏捷性的物流策略鋪平了道路。相關人員擴大利用雲端基礎的平台和即時追蹤系統來提供無與倫比的供應鏈可視性。這不僅最大限度地降低了中斷的風險，而且加強了每個階段的決策流程。永續和敏捷營運的驅動力正在推動溫控物流的進一步創新，以確保敏感的生物材料在運輸過程中保持其完整性。此外，跨部門合作正在推動先進製造技術和自動化包裝流程的整合。這些變化帶來了整個臨床試驗站點的業務效率的提升。隨著技術的發展，傳統的角色界線變得越來越模糊，帶來了多種專業知識的融合，可以最佳化成本控制和品質保證之間的平衡。這些轉型轉變正在為滿足現代臨床試驗動態需求的彈性供應生態系統奠定基礎。

推動市場動態的關鍵細分洞察

為了解讀臨床試驗供應和物流的複雜動態，徹底了解市場區隔至關重要。分析從所提供的服務開始，並根據不同的維度進行分類。市場細分涉及比較器採購、綜合物流和配送、精密製造、詳細包裝、準確標籤和盲法以及至關重要的儲存和保存等方面。在物流領域，演變進一步細分為低溫運輸分銷方法（對於維持溫度敏感的生技藥品至關重要）和適合更廣泛醫療產品的非低溫運輸分銷選項。此外，採購模式也受到嚴格審查，重點是集中式和分散式方法，每種方法在效率和成本最佳化方面都有各自的優勢。在考慮產品類型時，市場差異化也很重要，例如生物製藥、先進醫療設備和小分子療法。此外，我們透過比較異地和現場供應管理來檢視供應模式，這對時間和資源分配具有重要意義。最終用戶分析揭示了從委外研發機構和醫療設備公司到製藥和生物技術公司等各個相關人員的多樣化和專業化需求。最後，從血液學到呼吸系統疾病等治療領域都透過多階段臨床試驗的評估進行補充，從 BA/BE 試驗到第 4 階段，從而提供細緻入微的視角，以準確評估市場需求和機會。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 臨床試驗全球化與監理協調
      • 隨著慢性病發生率的上升，政府加大資金投入，推動整個經濟領域的醫藥研發活動
    • 限制因素
      • 與技術整合和數據管理相關的問題
    • 機會
      • 製藥公司與CDMO的合作活動增多
      • 整合人工智慧和機器學習，實現供應鏈最佳化中的預測分析
    • 任務
      • 與臨床試驗供應和物流業務相關的擔憂
  • 市場區隔分析
    • 服務：隨著需求的成長，低溫運輸配送服務不斷進步
    • 類型：小分子在醫藥領域的應用快速成長
    • 交付方式：擴大採用異地解決方案在多個地點進行測試
    • 採購模式：對分散採購模式的需求不斷成長，以提高供應分配的速度和效率
    • 階段：擴大三期臨床試驗的供應與物流服務範圍
    • 治療領域：私人和公共部門在腫瘤學領域的投資和研究活動激增
    • 最終用戶：製藥和生物技術公司擴大使用臨床試驗用品和物流
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 臨床試驗供應及物流市場（按服務）

  • 比較採購
  • 物流與配送
    • 低溫運輸運輸
    • 非低溫運輸運輸
  • 製造業
  • 包裝、標籤、百葉窗
  • 儲存和保留

第7章臨床試驗供應與物流市場（依採購模式）

  • 集中採購
  • 分散採購

8. 臨床試驗供應及物流市場（按類型）

  • 生物製藥
  • 醫療設備
  • 小分子

9. 臨床試驗供應及物流市場（以交付方式）

  • 異地供應管理
  • 現場供應管理

第 10 章臨床試驗供應和物流市場（按最終用戶）

  • 合約研究組織
  • 醫療設備公司
  • 製藥和生物技術公司

第11章臨床試驗供應與物流市場（依治療領域）

  • 血液系統疾病
  • 心血管疾病
  • 中樞神經系統和精神疾病
  • 皮膚病
  • 消化系統疾病
  • 耳鼻喉疾病
  • 免疫學
  • 感染疾病
  • 代謝紊亂
  • 腎臟病學
  • 腫瘤學
  • 罕見疾病
  • 呼吸系統疾病

第 12 章臨床試驗供應與物流市場（按臨床試驗階段）

  • 文學士/工學學士研究
  • 第一階段
  • 第 2 階段
  • 第 3 階段
  • 第四階段

13.美洲臨床試驗供應與物流市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

14. 亞太臨床試驗供應與物流市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

15.歐洲、中東和非洲臨床試驗供應和物流市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Acnos Pharma GmbH
  • ADAllen Pharma Ltd
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Beroe Holdings Inc.
  • Biocair International Limited
  • Calyx
  • Catalent, Inc.
  • Clinical Services International LTD
  • Clinigen Group PLC
  • COREX LOGISTICS LIMITED
  • DHL Group
  • Eurofins Scientific SE
  • Experic, LLC
  • FedEx Corporation
  • ICON PLC
  • Inceptua SA
  • Infosys Limited
  • IPS Pharma
  • KLIFO A/S
  • Lonza Group AG
  • Marken Limited by United Parcel Service, Inc.
  • Microsoft Corporation
  • Myonex, Inc.
  • N-SIDE SA
  • NUVISAN GmbH
  • OCT Clinical GmbH
  • Octalsoft
  • Parexel International Corporation
  • PCI Pharma Services
  • PHOENIX Pharmahandel GmbH & Co KG
  • Piramal Pharma Limited
  • Recipharm AB
  • SAP SE
  • Sharp Services, LLC
  • Signant Health
  • SIRO Clinpharm Private Limited
  • Thermo Fisher Scientific Inc.
  • Tower Cold Chain Solutions
  • Uniphar PLC
  • Walden Group
  • Zuellig Pharma Pte Ltd by Interpharma Investments Limited
Product Code: MRR-501246436315

The Clinical Trial Supply & Logistics Market was valued at USD 24.33 billion in 2023 and is projected to grow to USD 26.20 billion in 2024, with a CAGR of 7.75%, reaching USD 41.04 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 24.33 billion
Estimated Year [2024] USD 26.20 billion
Forecast Year [2030] USD 41.04 billion
CAGR (%) 7.75%

In today's fast-paced environment, the clinical trial supply and logistics sector stands as a vital cog in the drug development process. The once traditional methods are rapidly evolving to address an increasingly demanding landscape, characterized by complex research protocols, heightened regulatory requirements, and a global network of clinical sites. This report offers a comprehensive overview of the state-of-the-art methodologies emerging in the industry and sets the stage for an in-depth examination of market dynamics. The narrative is built on the convergence of cutting-edge technologies, innovative sourcing strategies, and adaptive logistics solutions that cater to the nuances of clinical trials at every stage. Recognizing the importance of maintaining both the integrity and timely delivery of sensitive trial materials, industry leaders have been compelled to reimagine their supply chains. As the industry moves towards a more integrated and holistic approach, every facet-from manufacturing and packaging to labeling and storage-has come under scrutiny. The discussion highlights the progressive steps taken by various stakeholders to streamline operations, ensuring that novel therapies reach those in need efficiently and safely.

Transformative Shifts Reshaping the Clinical Trial Landscape

Over recent years, the industry has witnessed several transformative shifts that have redefined how clinical trial supplies are managed. Advancements in digital connectivity, combined with robust data analytics, have paved the way for more predictive and responsive logistic strategies. Stakeholders are increasingly leveraging cloud-based platforms and real-time tracking systems that offer unparalleled visibility into the supply chain. This not only minimizes the risk of disruption but also enhances decision-making processes at every juncture. A move towards sustainable and agile operations has further spurred innovations in temperature-controlled logistics, ensuring that sensitive biological materials maintain their integrity during transit. Moreover, collaborations across sectors have led to the integration of advanced manufacturing techniques and automated packaging processes. Such changes have resulted in operational efficiencies that ripple throughout the clinical trial landscape. As techniques evolve, the boundaries between traditional roles blur, ushering in a convergence of expertise that optimizes the balance between cost management and quality assurance. These transformative shifts are laying the foundation for a supply ecosystem that is both resilient and responsive to the dynamic needs of modern clinical trials.

Key Segmentation Insights Driving Market Dynamics

A refined understanding of the market segmentation is paramount for deciphering the intricate dynamics of clinical trial supply and logistics. The analysis is categorized under various dimensions beginning with the services provided. The market is dissected across facets including comparator sourcing, comprehensive logistics and distribution, precise manufacturing, detailed packaging, accurate labeling and blinding, as well as critical storage and retention. Within logistics, the evolution is further delineated into cold chain distribution methods that are essential for maintaining temperature-sensitive biologics and non-cold chain distribution options catering to a broader spectrum of medical products. Additionally, sourcing models are scrutinized with a focus on centralized versus decentralized approaches, each presenting unique benefits in terms of efficiency and cost optimization. Critical market differentiation also emerges when examining the types of products, spanning biologic drugs, advanced medical devices, and small molecule therapies. Furthermore, the mode of delivery is scrutinized by contrasting offsite supply management against onsite supply management, which has significant implications on timing and resource allocation. End-user analysis extends from contract research organizations and medical devices companies to pharmaceutical and biotechnology companies, underscoring the diverse and specialized needs of various stakeholders. Lastly, therapeutic areas from blood disorders to respiratory challenges, complemented by an evaluation of multiple phases of clinical trials from BA/BE studies through Phase 4, provide a nuanced lens through which market needs and opportunities can be accurately assessed.

Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.

Based on Sourcing Model, market is studied across Centralized Sourcing and Decentralized Sourcing.

Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.

Based on Mode of Delivery, market is studied across Offsite Supply Management and Onsite Supply Management.

Based on End-user, market is studied across Contract Research Organisations, Medical Devices Companies, and Pharmaceutical & Biotechnology Companies.

Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.

Based on Phases of Clinical Trials, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.

Regional Dynamics and Market Opportunities

The clinical trial supply and logistics market is visibly segmented by distinct regional trends that influence strategic decisions and operational frameworks. In the Americas, mature regulatory landscapes and advanced healthcare infrastructures are propelling market growth, with a particular focus on innovations that improve trial efficiencies and reduce lead times. Meanwhile, the combined dynamics of Europe, the Middle East, and Africa present a compelling mix of regulatory rigor and emerging opportunities. These regions are harnessing the benefits of technological integration and collaborative supply chain practices to tackle unique challenges intrinsic to local healthcare systems. The Asia-Pacific region is rapidly asserting its position on the global stage as an epicenter for clinical research and development. Driven by substantial investments in research infrastructure and a vast patient demographic pool, the region is witnessing remarkable improvements in logistics capabilities and an increasing adoption of technology-driven solutions. In each of these markets, the balance between localized operational strategies and global best practices is key to sustaining momentum and fostering growth. Understanding these geographical nuances not only enhances the ability to anticipate market shifts but also empowers stakeholders to design region-specific strategies that align with broader global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Players and Competitive Strategies

The market landscape is further enriched by a competitive array of key companies that have robustly positioned themselves at various stages of the clinical trial supply chain. Companies such as Acnos Pharma GmbH and ADAllen Pharma Ltd have developed specialized capabilities in supply chain management, while industry leaders including Almac Group Limited, Ancillare, LP, and Avantor, Inc. continue to push boundaries with innovative logistical solutions. Other notable players such as Beroe Holdings Inc. and Biocair International Limited are known for their stringent quality controls and reliable distribution networks. The competitive environment is bolstered by significant contributions from Calyx, Catalent, Inc., and Clinical Services International LTD, along with influential operations led by Clinigen Group PLC and COREX LOGISTICS LIMITED. Furthermore, global logistics giants like DHL Group, FedEx Corporation, and Tower Cold Chain Solutions are instrumental in driving supply chain optimization. In this complex ecosystem, organizations including Eurofins Scientific SE, Experic, LLC, ICON PLC, and Inceptua S.A. have also emerged as front-runners. The presence of technology powerhouses such as Infosys Limited and SAP SE, combined with strong performances from specialized entities like IPS Pharma and KLIFO A/S, enriches the competitive tapestry. Collectively, these players contribute to a dynamic market environment that rewards innovation, operational excellence, and a commitment to sustained improvement in clinical supply chain processes.

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited. Actionable Recommendations for Advancing Market Leadership

Industry leaders are encouraged to embrace a multi-pronged approach to secure a competitive edge and streamline operations in a rapidly evolving market. First, there is an immediate need to invest in digital transformation initiatives, including the integration of real-time tracking systems and advanced analytics platforms to foster greater supply chain visibility and risk mitigation. It is essential to cultivate partnerships that bridge the gaps between manufacturing, packaging, and distribution, ensuring that the entire supply chain remains cohesive and resilient. Emphasizing a shift towards centralized or, where beneficial, decentralized sourcing strategies can help optimize resource allocation and manage regional demands effectively. Furthermore, aligning with specialized service providers that offer bespoke solutions across comparator sourcing and cold chain logistics will fortify the ability to handle sensitive trial materials. Leaders should also consider diversifying their operational frameworks by leveraging offsite and onsite supply management models that accommodate the evolving requirements of varied therapeutic areas and clinical trial phases. Strategic investments in automation, data analytics, and sustainable logistic practices can dramatically reduce turnaround times while enhancing cost efficiency. Embracing these actionable strategies not only reinforces current operational frameworks but also positions organizations to anticipate future market challenges with agility and precision.

Conclusion and Forward Outlook

In summary, the clinical trial supply and logistics market is undergoing a significant transformation driven by technological advancements and innovative operational strategies. The integrated approach to managing segmented market needs-from services and sourcing models to therapeutic areas and trial phases-underscores a deep commitment to enhancing efficiency and ensuring the successful execution of clinical research. As regional markets evolve and competitive pressures intensify, a strategic, data-informed, and agile methodology remains a critical success factor. The momentum generated by these evolving trends paints an optimistic future where operational excellence and technological integration coalesce to drive transformative outcomes across the industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Globalization of clinical trials and harmonization of regulations
      • 5.1.1.2. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with technology integration and data management
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
      • 5.1.3.2. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
    • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
    • 5.2.3. Mode of Delivery: Growing adoption of offsite solutions for multi-site trials delivery
    • 5.2.4. Sourcing Model: Rising demand for decentralized sourcing models to enhance the speed and efficiency of supply distribution
    • 5.2.5. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
    • 5.2.6. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
    • 5.2.7. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Supply & Logistics Market, by Services

  • 6.1. Introduction
  • 6.2. Comparator Sourcing
  • 6.3. Logistics & Distribution
    • 6.3.1. Cold Chain Distribution
    • 6.3.2. Non-Cold Chain Distribution
  • 6.4. Manufacturing
  • 6.5. Packaging, Labeling, & Blinding
  • 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Sourcing Model

  • 7.1. Introduction
  • 7.2. Centralized Sourcing
  • 7.3. Decentralized Sourcing

8. Clinical Trial Supply & Logistics Market, by Type

  • 8.1. Introduction
  • 8.2. Biologic Drugs
  • 8.3. Medical Devices
  • 8.4. Small Molecules

9. Clinical Trial Supply & Logistics Market, by Mode of Delivery

  • 9.1. Introduction
  • 9.2. Offsite Supply Management
  • 9.3. Onsite Supply Management

10. Clinical Trial Supply & Logistics Market, by End-user

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Medical Devices Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Clinical Trial Supply & Logistics Market, by Therapeutic Area

  • 11.1. Introduction
  • 11.2. Blood Disorders
  • 11.3. Cardiovascular Diseases
  • 11.4. CNS & Mental Disorders
  • 11.5. Dermatological Disorders
  • 11.6. Digestive Disorders
  • 11.7. ENT Diseases
  • 11.8. Immunology
  • 11.9. Infectious Diseases
  • 11.10. Metabolic Disorders
  • 11.11. Nephrology
  • 11.12. Oncology
  • 11.13. Rare Diseases
  • 11.14. Respiratory Disorders

12. Clinical Trial Supply & Logistics Market, by Phases of Clinical Trials

  • 12.1. Introduction
  • 12.2. BA/ BE studies
  • 12.3. Phase 1
  • 12.4. Phase 2
  • 12.5. Phase 3
  • 12.6. Phase 4

13. Americas Clinical Trial Supply & Logistics Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Clinical Trial Supply & Logistics Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Catalent strengthens European supply chain with USD 25 million expansion of Schorndorf facility, enhancing FastChain capabilities
    • 16.3.2. Experic strategically expands to Europe with a new Dublin facility enhancing global clinical trial supply and logistics services
    • 16.3.3. FedEx fortifies its global clinical trial logistics with a new life science center in Mumbai, enhancing healthcare supply chain connectivity
    • 16.3.4. PCM Trials acquires Netherlands-based clinical trial service
    • 16.3.5. Piramal Pharma solutions commemorates opening of its ADC manufacturing expansion in Grangemouth, Scotland
    • 16.3.6. Biocair announces the U.S. expansion as part Of global growth strategy
    • 16.3.7. Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs
    • 16.3.8. Piramal Pharma Solutions launches in-vitro biology capabilities at Ahmedabad discovery services site
    • 16.3.9. Signant Health Launches Signant Biotech to accelerate and streamline clinical development for emerging biopharmaceutical organizations
    • 16.3.10. N-SIDE introduces Lighthouse, innovative software to shape the future of worldwide clinical trial supply management
    • 16.3.11. Zuellig Pharma and GSK establish a vaccine distribution hub in Singapore
    • 16.3.12. Ariceum Therapeutics and Eurofins CDMO sign a pharmaceutical multi-project agreement
    • 16.3.13. Vial announces strategic partnership with Royale International Group
    • 16.3.14. Biocair partners with TrakCel to improve visibility in the supply chain
    • 16.3.15. IDEAYA expands clinical trial collaboration and supply agreements with Pfizer
    • 16.3.16. Calyx introduces new clinical trial supply forecasting service
    • 16.3.17. Catalent completes expansion of Singapore clinical supply facility for increased temperature-controlled capabilities
  • 16.4. Strategy Analysis & Recommendation
    • 16.4.1. Almac Group Limited
    • 16.4.2. Catalent, Inc.
    • 16.4.3. DHL Group
    • 16.4.4. Walden Group

Companies Mentioned

  • 1. Acnos Pharma GmbH
  • 2. ADAllen Pharma Ltd
  • 3. Almac Group Limited
  • 4. Ancillare, LP
  • 5. Avantor, Inc.
  • 6. Beroe Holdings Inc.
  • 7. Biocair International Limited
  • 8. Calyx
  • 9. Catalent, Inc.
  • 10. Clinical Services International LTD
  • 11. Clinigen Group PLC
  • 12. COREX LOGISTICS LIMITED
  • 13. DHL Group
  • 14. Eurofins Scientific SE
  • 15. Experic, LLC
  • 16. FedEx Corporation
  • 17. ICON PLC
  • 18. Inceptua S.A.
  • 19. Infosys Limited
  • 20. IPS Pharma
  • 21. KLIFO A/S
  • 22. Lonza Group AG
  • 23. Marken Limited by United Parcel Service, Inc.
  • 24. Microsoft Corporation
  • 25. Myonex, Inc.
  • 26. N-SIDE SA
  • 27. NUVISAN GmbH
  • 28. OCT Clinical GmbH
  • 29. Octalsoft
  • 30. Parexel International Corporation
  • 31. PCI Pharma Services
  • 32. PHOENIX Pharmahandel GmbH & Co KG
  • 33. Piramal Pharma Limited
  • 34. Recipharm AB
  • 35. SAP SE
  • 36. Sharp Services, LLC
  • 37. Signant Health
  • 38. SIRO Clinpharm Private Limited
  • 39. Thermo Fisher Scientific Inc.
  • 40. Tower Cold Chain Solutions
  • 41. Uniphar PLC
  • 42. Walden Group
  • 43. Zuellig Pharma Pte Ltd by Interpharma Investments Limited

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET MULTI-CURRENCY
  • FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET MULTI-LANGUAGE
  • FIGURE 3. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
  • FIGURE 4. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2023 VS 2030 (%)
  • FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 30. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 31. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CENTRALIZED SOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DECENTRALIZED SOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY OFFSITE SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONSITE SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 88. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 166. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 167. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 183. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 184. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 191. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 192. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 194. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 198. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 199. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 200. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 202. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 215. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 216. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 217. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 219. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 223. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 224. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 225. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 227. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 229. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 231. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 232. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 233. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 235. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 237. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 239. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 240. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 241. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 243. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 245. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 247. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 248. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 249. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 251. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 253. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 255. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 256. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 257. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 259. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 261. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 263. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 264. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 265. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 267. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 269. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 272. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 279. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 280. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 281. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 283. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 285. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 287. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 288. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
  • TABLE 289. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 291. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 293. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 295. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD